Decision support systems for incurable non-small cell lung cancer: a systematic review-Reference-Cited by-同舟云学术

Decision support systems for incurable non-small cell lung cancer: a systematic review

Published:2017-10-02 Issue:1 Volume:17 Page:
ISSN:1472-6947
Container-title:BMC Medical Informatics and Decision Making
language:en
Short-container-title:BMC Med Inform Decis Mak

Author:

Révész D.^ORCID,Engelhardt E. G.,Tamminga J. J.,Schramel F. M. N. H.,Onwuteaka-Philipsen B. D.,van de Garde E. M. W.,Steyerberg E. W.,Jansma E. P.,De Vet H. C. W.,Coupé V. M. H.

Funder

The National Health Care Institute (ZIN: Zorginstituut Nederland)

Publisher

Springer Science and Business Media LLC

Subject

Health Informatics,Health Policy,Computer Science Applications

Link

http://link.springer.com/content/pdf/10.1186/s12911-017-0542-1.pdf

Reference77 articles.

1. World Health Organization Cancer Fact sheet [updated 01–02-2015. Available from: http://www.who.int/mediacentre/factsheets/fs297/en/ . Accessed 6 Oct 2016.

2. American Cancer Society [updated 01–07-2016. Available from: http://www.cancer.org/acs/groups/cid/documents/webcontent/003115-pdf.pdf . Accessed 6 Oct 2016.

3. Goldstraw P, Ball D, Jett JR, Le Chevalier T, Lim E, Nicholson AG, et al. Non-small-cell lung cancer. Lancet. 2011;378(9804):1727–40.

4. Sculier JP, Meert AP. Third-generation chemotherapy agents in the treatment of advanced non-small cell lung cancer: a meta-analysis. J Thorac Oncol. 2008;3, 320(3) author reply -2

5. Incidentie-, prevalentie- en sterftecijfers: Nederlandse Kankerregistratie beheerd door IKNL; 2016 [updated 04–02-2016. Available from: http://www.cijfersoverkanker.nl . Accessed 6 Oct 2016.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Framework for Lung Cancer Detection at Early Stages with IoT and Decision Support System;2023 International Conference on Innovation and Intelligence for Informatics, Computing, and Technologies (3ICT);2023-11-20

2. Exploring the impact of patient‐specific clinical features on osimertinib effectiveness in a real‐world cohort of patients with EGFR mutated non‐small cell lung cancer;International Journal of Cancer;2023-10-15

3. External Validation of Robust Radiomic Signature to Predict 2-Year Overall Survival in Non-Small-Cell Lung Cancer;Journal of Digital Imaging;2023-09-21

4. “The challenge is the complexity” – A qualitative study about decision-making in advanced lung cancer treatment;Lung Cancer;2023-09

5. Clinician perspectives on clinical decision support systems in lung cancer: Implications for shared decision‐making;Health Expectations;2022-05-10